MSB 2.98% $1.47 mesoblast limited

Cell Therapy News/Articles, page-8214

  1. 2,274 Posts.
    lightbulb Created with Sketch. 374
    whoa 1650 is huge. He basically says they have already looked at the data for the subset of patients on entresto having done better? Also sounds definite on partnership on chf Novartis and milestone payments from grun. He said they are moving into reg approval mode for clbp and chf. ☺️
    min topping up today.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.